We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, August 14th:
SYNNEX Corporation (SNX - Free Report) : This provider of business process services, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.6% over the last 60 days.
Gildan Activewear Inc. (GIL - Free Report) : This manufacturer of everyday basic apparel, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.5% over the last 60 days.
Crocs, Inc. (CROX - Free Report) : This retailer of casual footwear for women, men and children, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 12% over the last 60 days.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Top Ranked Growth Stocks to Buy for August 15th
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, August 14th:
SYNNEX Corporation (SNX - Free Report) : This provider of business process services, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.6% over the last 60 days.
SYNNEX Corporation Price and Consensus
SYNNEX Corporation price-consensus-chart | SYNNEX Corporation Quote
SYNNEX has a PEG ratio 0.56, compared with 1.03 for the industry. The company possesses a Growth Score of A.
SYNNEX Corporation PEG Ratio (TTM)
SYNNEX Corporation peg-ratio-ttm | SYNNEX Corporation Quote
Gildan Activewear Inc. (GIL - Free Report) : This manufacturer of everyday basic apparel, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.5% over the last 60 days.
Gildan Activewear, Inc. Price and Consensus
Gildan Activewear, Inc. price-consensus-chart | Gildan Activewear, Inc. Quote
Gildan has a PEG ratio 1.27, compared with 1.38 for the industry. The company possesses a Growth Score of B.
Gildan Activewear, Inc. PEG Ratio (TTM)
Gildan Activewear, Inc. peg-ratio-ttm | Gildan Activewear, Inc. Quote
Crocs, Inc. (CROX - Free Report) : This retailer of casual footwear for women, men and children, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 12% over the last 60 days.
Crocs, Inc. Price and Consensus
Crocs, Inc. price-consensus-chart | Crocs, Inc. Quote
Crocs has a PEG ratio 1.14, compared with 1.38 for the industry. The company possesses a Growth Score of A.
Crocs, Inc. PEG Ratio (TTM)
Crocs, Inc. peg-ratio-ttm | Crocs, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Growth score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>